查詢結果分析
相關文獻
- Treatment Experience of Taiwanese Patients with Anti3-hydroxy-3-methylglutaryl-coenzyme a Reductase Myopathy
- 抗癌新藥Rituximab--以抗CD20單株抗體來治療復發性低惡性度非何杰金氏淋巴瘤
- 免疫球蛋白
- Rituximab(Mabthera[feb9])--治療B細胞非何杰金氏淋巴瘤有新藥
- IgA腎病近年來的發展
- 疑似Rituximab引起之輸注不良反應
- Waldenström Macroglobulinemia導致Pseudohypoglycemia之案例報告
- 疑似Rituximab引起之B型肝炎病毒再活化
- Reverse Expression of α2,6-sialic Acid Ratios on IgG, IgM, and IgG/IgM Autoantibodies Correlates with Mouse Arthritis and Rheumatoid Arthritis Disease Activity
- Intravenous Immunoglobulin Remain a Source of Bias in the Interpretation of Infectious Disease Serology among Clinicians
頁籤選單縮合
題名 | Treatment Experience of Taiwanese Patients with Anti3-hydroxy-3-methylglutaryl-coenzyme a Reductase Myopathy |
---|---|
作者 | Liang, Wen-chen; Wang, Chen-hua; Chen, Wan-zi; Kuo, Yun-ting; Lin, Hsiu-fen; Suzuki, Shigeaki; Nishino, Ichizo; Jong, Yuh-jyh; | 書刊名 | The Kaohsiung Journal of Medical Sciences |
卷期 | 36:8 2020.08[民109.08] |
頁次 | 頁649-655 |
分類號 | 415.9413 |
關鍵詞 | Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy; Immune-mediated necrotizing myopathy; Immunoglobulin; Magnetic resonance imaging; Rituximab; |
語文 | 英文(English) |